Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.3K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.4K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Opa1</i>-Knocked out EMSCs-Derived EV-Mito Empower Functionalized PEEK/LL37 Scaffolds to Combat Drug-Resistant Bone Infection.

ACS applied materials & interfaces·2026
Same author

Associations of Dietary Patterns and Micronutrients With Major Adverse Cardiovascular Events and Mortality Among Populations With Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: Results From Two Prospective Cohorts.

Food science & nutrition·2026
Same author

Occlusal types shape oral microbiome stomatotypes and metabolic landscapes: A multi-omics perspective on host-microbe interaction.

Microbial cell (Graz, Austria)·2026
Same author

Unveiling the cadmium tolerance mechanisms of endophytic PGPB Pantoea sp. EEL5 isolated from Thinopyrum elongatum and its bioremediation for acidic cadmium-contaminated soil.

Microbiological research·2026
Same author

Combined metformin and Taurine attenuate age-related bone loss.

Molecular biology reports·2026
Same author

Development of Bacillus subtilis cell factories for nutraceuticals production.

World journal of microbiology & biotechnology·2026

Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Pocket2Drug: An Encoder-Decoder Deep Neural Network for the Target-Based Drug Design.

Wentao Shi1, Manali Singha2, Gopal Srivastava2

  • 1Division of Electrical and Computer Engineering, Louisiana State University, Baton Rouge, LA, United States.

Frontiers in Pharmacology
|April 1, 2022
PubMed
Summary

Pocket2Drug, a deep graph neural network, enhances drug discovery by predicting molecules that bind to target proteins. This computational model significantly improves the identification of promising drug candidates for various diseases.

Keywords:
deep learningdrug discovery and developmentgenerative modelgraph neural networkin silico drug designligand binding sitesmachine learningrecurrent neural network

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

567
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

Related Experiment Videos

Last Updated: Sep 28, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

567
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Machine learning in drug discovery

Background:

  • Modern drug discovery relies heavily on computational modeling to identify potential drug candidates for target proteins.
  • Advances in structural biology reveal numerous disease-related protein binding sites, creating opportunities for computational prediction models.

Purpose of the Study:

  • To introduce Pocket2Drug, a deep graph neural network model designed to predict small molecules that bind to specific ligand binding sites.
  • To leverage data mining and machine learning for efficient computational models in drug candidate selection.

Main Methods:

  • Pocket2Drug utilizes a deep graph neural network architecture.
  • The model is trained on a large dataset of protein pocket structures to learn the probability distribution of small molecules.
  • Drug candidates are sampled from the trained model for prediction.

Main Results:

  • Pocket2Drug significantly enhances the success rate of identifying molecules that bind to target pockets compared to traditional methods.
  • The model successfully generated known binders for 80.5% of targets in a diverse, independent testing set.
  • Performance was validated against a testing set distinct from the training data.

Conclusions:

  • Pocket2Drug represents a promising computational approach for accelerating the discovery of novel biopharmaceuticals.
  • The model's ability to predict binding molecules offers a valuable tool for informing drug discovery pipelines.